Abeona Therapeutics (NASDAQ:ABEO) initiated with Outperform rating and $6 (139% upside) price target at SVB Leerink. Shares up 8% premarket.
Akero Therapeutics (NASDAQ:AKRO) initiated with Buy rating and $36 (38% upside) price target at Canaccord Genuity.
Ardelyx (NASDAQ:ARDX) initiated with Outperform rating at Cowen and Company.
Well Health Technologies (WELL CN) initiated with
Hold rating and C$1.80 (5% downside risk) price target at Canaccord.
U.S. ticker: (OTCPK:WLYYF).
Adverum Biotechnologies (NASDAQ:ADVM) upgraded to Overweight with a $21 (105% upside) price target at Cantor Fitzgerald. Shares up 20% premarket on positive gene therapy data.
https://seekingalpha.com/news/3539998-cantor-upgrades-adverum-on-positive-advmminus-022-data
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.